Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

NCT00705172 · clinicaltrials.gov ↗

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Genetic Disorder
Prader-Willi Syndrome

Interventions

DRUG: somatropin

Sponsor

Novo Nordisk A/S